Agios Pharmaceuticals shares owned by Connor, Clark & Lunn Investment Management
Quarter-by-quarter ownership of Agios Pharmaceuticals (AGIO) shares owned by Connor, Clark & Lunn Investment Management
from 13F filings
Historical chart of Connor, Clark & Lunn Investment Management investment in Agios Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Agios Pharmaceuticals held by Connor, Clark & Lunn Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Agios Pharmaceuticals by Connor, Clark & Lunn Investment Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $226k | 10k | 22.27 |
| 2023-06-30 | $2.3M | 80k | 28.32 |
| 2023-03-31 | $2.8M | 123k | 22.97 |
| 2022-12-31 | $4.3M | 152k | 28.08 |
| 2022-09-30 | $5.5M | 194k | 28.28 |
| 2022-06-30 | $3.1M | 142k | 22.17 |
| 2022-03-31 | $3.2M | 109k | 29.11 |
| 2021-12-31 | $2.8M | 86k | 32.87 |
| 2021-09-30 | $4.8M | 104k | 46.15 |
| 2021-06-30 | $1.4M | 26k | 55.12 |
| 2021-03-31 | $442k | 8.6k | 51.61 |
More positions owned by Connor, Clark & Lunn Investment Management
View all positions for Connor, Clark & Lunn Investment Management